Ovarian Clinical Trials in Chongqing, Chongqing Municipality
8 recruitingChongqing, Chongqing Municipality, China
Showing 1–8 of 8 trials
Recruiting
Phase 1Phase 2
Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
Ovarian CancerPancreatic CarcinomaAdvanced Solid Tumors+1 more
Evopoint Biosciences Inc.350 enrolled24 locationsNCT06799637
Recruiting
Phase 1Phase 2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Endometrial CancerPrimary Peritoneal CarcinomaNon-small Cell Lung Cancer+6 more
Genmab764 enrolled66 locationsNCT05579366
Recruiting
Phase 1Phase 2
Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors
Breast CancerOvarian CancerProstate Cancer+3 more
Acerand Therapeutics (Shanghai) Limited298 enrolled14 locationsNCT06380660
Recruiting
Phase 3
Study of IBI354 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Fallopian Tube CancerPrimary PeritonealOvarian
Innovent Biologics (Suzhou) Co. Ltd.450 enrolled1 locationNCT06834672
Recruiting
Phase 2
HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer
Ovarian CancerEndometrial CancerPrimary Peritoneal Cancer+1 more
Hansoh BioMedical R&D Company460 enrolled28 locationsNCT06014190
Recruiting
Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids
Ovarian Cancer
Chongqing University Cancer Hospital100 enrolled1 locationNCT06317610
Recruiting
Phase 2
Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi
Ovarian Cancer
Chongqing University Cancer Hospital42 enrolled1 locationNCT05551208
Recruiting
Not Applicable
Chemotherapy Supported by Autologous Hematopoietic Stem Cells
Ovarian Cancer
Chongqing University Cancer Hospital40 enrolled1 locationNCT05401162